Highland Crusader Offshore v Targeted Delivery Technologies

Motion No: M-7561

Slip Opinion No: 2019 NYSlipOp 83507(U)

Decided on November 7, 2019

Appellate Division, First Department, Motion Decision

Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.

This motion is uncorrected and is not subject to publication in the Official Reports.

November 7, 2019

Highland Crusader Offshore

Partners, L.P., Highland Credit

Opportunities CDO, Ltd, Highland Credit

Strategies Master Fund, L.P., Highland

Restoration Capital Partners Master, L.P.,

and Nexpoint Credit Strategies Fund,

Plaintiffs-Respondents,

v

Targeted Delivery Technologies

Holdings, Ltd., Targeted Delivery

Technologies, Ltd., Celtic Pharmaceutical

Holdings, L.P., Celtic Pharma Development

Services Bermuda, Ltd, Celtic

Therapeutics Management LLLP, doing business

as Auven Therapeutic Management LLLP and as

Successor-in-interest to Celtic Pharma

Management, L.P., Celtic Pharma

Management Company, Ltd., Celtic Pharma

Fix, Ltd, Celtic Pharma Fix Venture, Ltd.,

Stephen Evans-Freke and John Mayo,

Defendants-Appellants.

Appeals having been taken from an order of the Supreme Court, New York County, entered on or about December 4, 2018, Now, upon reading and filing the stipulation of the parties hereto, dated September 18, 2019, and due deliberation having been had thereon, It is ordered that the appeal taken by defendant-appellant Stephen Evans-Freke is deemed withdrawn in accordance with the aforesaid stipulation.ENTERED: November 7, 2019

_____________________ CLERK

PRESENT: Hon. Rolando T. Acosta,Presiding Justice,David Friedman John W. Sweeny, Jr. Dianne T. Renwick Rosalyn H. Richter,Justices

M-7561

Index No. 653486/16